Astonea Labs Ltd. (ASTONEALAB) — BSE Stock Analysis
Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹256.10.
Company Overview
Astonea Labs Ltd. is a pharmaceutical and cosmeceutical manufacturing company based in Panchkula, Haryana, India. The company specializes in the formulation and large-scale production of a diverse range of products, including prescription medicines such as antibiotics, anti-cold drugs, antihistamines, diabetes medications, cardiovascular treatments, gynecological therapies, antifungal agents, analgesics, and multivitamins. In addition, Astonea Labs offers a wide array of personal care and cosmetic products, including formulations for skin, dental, and hair care presented as gels, ointments, creams, lotions, oils, and serums. With a manufacturing infrastructure that is compliant with WHO GMP, ISO, CE, PETA, HALAL, ECO CERT, and other international standards, Astonea Labs operates as both an original equipment manufacturer (OEM) and a contract producer for third-party brands across pharmaceutical, herbal, nutraceutical, and cosmetic categories. Founded in 2017, the company combines advanced research and development capabilities with significant production capacity, serving both domestic and international markets. Astonea Labs Ltd. plays a key role in the healthcare and personal care industries, recognized for its focus on quality, regulatory compliance, and scalable manufacturing solutions.
Valuation Snapshot
- Market cap: —
- P/E: —
- P/B: —
- ROE: —
Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.